{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:51:11Z","timestamp":1793825471379,"version":"4.6.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Society for Rheumatology and Clinical Immunology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Polymyalgia rheumatica (PMR) is the second most frequent inflammatory rheumatic disease in older adults, after rheumatoid arthritis. Recommendations for the management of PMR, developed by the German, Austrian and Swiss societies of rheumatology and other organizations were published in 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>These recommendations are now updated based on a systematic literature search that covered the evidence published between July 2016 and January 2024 on therapeutic interventions and prognostic factors for PMR. The search string followed that used in the original recommendations, with an extension for targeted synthetic disease-modifying antirheumatic drugs (DMARDs). Based on evidence and expert opinions, the task force (12 physicians, two healthcare professionals and two patients from three countries) developed a set of four overarching principles and seven specific recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The current update reiterates previous guideline recommendations for glucocorticoids (15\u201325\u2009mg prednisone equivalents per day) as initial treatment for PMR once diagnosis has been confirmed, with subsequent tapering over 4\u201312\u2009months (depending on whether a glucocorticoid sparing agent is used), with monitoring of disease activity and treatment-related adverse effects. Interleukin-6 receptor blocking agents should be considered in addition to glucocorticoids in patients with relapsing disease and can be considered in patients with new-onset PMR at high risk for glucocorticoid-related adverse events. Methotrexate or rituximab may be alternatives. Older and frail patients should also be offered an individualized exercise program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These updated recommendations should serve as an aid to evidence-based decisions ensuring high-quality care for all patients with PMR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf646","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:17:04Z","timestamp":1764767824000},"source":"Crossref","is-referenced-by-count":9,"title":["Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumatica"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2534-550X","authenticated-orcid":false,"given":"Frank","family":"Buttgereit","sequence":"first","affiliation":[{"name":"Medizinische Klinik m. S. Rheumatologie und Klinische Immunologie, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Gliedk\u00f6rperschaft der Freien Universit\u00e4t Berlin und Humboldt-Universit\u00e4t zu Berlin , Berlin,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhivana","family":"Boyadzhieva","sequence":"additional","affiliation":[{"name":"Medizinische Klinik m. S. Rheumatologie und Klinische Immunologie, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Gliedk\u00f6rperschaft der Freien Universit\u00e4t Berlin und Humboldt-Universit\u00e4t zu Berlin , Berlin,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Reisch","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Medical University of Graz , Graz,","place":["\u00d6sterreich"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Rheumatologie und Hiller Forschungszentrum f\u00fcr Rheumatologie, UKD, Heinrich-Heine-Universit\u00e4t , D\u00fcsseldorf,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brabant","sequence":"additional","affiliation":[{"name":"Kardiologisch-Angiologische Praxis Herzzentrum Bremen , Bremen,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-9613","authenticated-orcid":false,"given":"Thomas","family":"Daikeler","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Rheumatologie, Universit\u00e4tsspital Basel , Basel,","place":["Schweiz"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Duftner","sequence":"additional","affiliation":[{"name":"Medizinische Universit\u00e4t Innsbruck, Univ.-Klinik f. Innere Medizin II , Innsbruck,","place":["\u00d6sterreich"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Erstling","sequence":"additional","affiliation":[{"name":"Fachverband Rheumatologische Fachassistenz e. V. , Bergisch Gladbach,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Garske","sequence":"additional","affiliation":[{"name":"Deutsche Rheuma-Liga Bundesverband e. V. , Bonn,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8014-1801","authenticated-orcid":false,"given":"Bernhard","family":"Hellmich","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin, Rheumatologie, Pneumologie, Nephrologie und Diabetologie, Medius Klinken, Akademisches Lehrkrankenhaus der Universit\u00e4t T\u00fcbingen , Kirchheim unter Teck,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-109X","authenticated-orcid":false,"given":"Diego","family":"Kyburz","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Rheumatologie, Universit\u00e4tsspital Basel , Basel,","place":["Schweiz"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anett","family":"Rei\u00dfhauer","sequence":"additional","affiliation":[{"name":"Arbeitsbereich Physikalische Medizin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Gliedk\u00f6rperschaft der Freien Universit\u00e4t Berlin und Humboldt-Universit\u00e4t zu Berlin , Berlin,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Reu\u00df-Borst","sequence":"additional","affiliation":[{"name":"Schwerpunkt-Praxis f\u00fcr Rheumatologie, HESCURO-Klinik Bad Bocklet , Bad Bocklet, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Scheuermann","sequence":"additional","affiliation":[{"name":"Deutsche Rheuma-Liga Bundesverband e. V. , Bonn,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Steffens-Korbanka","sequence":"additional","affiliation":[{"name":"Rheumapraxis an der Hase , Osnabr\u00fcck,","place":["Deutschland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L","family":"Matteson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Mayo Clinic College of Medicine and Science , Rochester, MN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-0668","authenticated-orcid":false,"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[{"name":"Dienst f\u00fcr Rheumatologie, S\u00fcdtiroler Sanit\u00e4tsbetrieb (ASAA-SABES), Lehrkrankenhaus der Paracelsius Universit\u00e4t, Bruneck, Italien und Abteilung f\u00fcr Rheumatologie, Medizinische Universit\u00e4t Graz , Graz,","place":["\u00d6sterreich"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2026022606033325800_keaf646-B1","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"2026022606033325800_keaf646-B2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40266-019-00705-5","article-title":"Pathogenesis, diagnosis and management of polymyalgia rheumatica","volume":"36","author":"Camellino","year":"2019","journal-title":"Drugs Aging"},{"key":"2026022606033325800_keaf646-B3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00393-016-0105-3","article-title":"[Diagnostics and treatment of polymyalgia rheumatica]","volume":"75","author":"Dejaco","year":"2016","journal-title":"Z Rheumatol"},{"key":"2026022606033325800_keaf646-B4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Gonzalez-Gay","year":"2017","journal-title":"Lancet"},{"key":"2026022606033325800_keaf646-B5","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026022606033325800_keaf646-B6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00393-018-0476-8","article-title":"S3 guidelines on treatment of polymyalgia rheumatica: evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of Rheumatology and Rehabilitation (OGR) and the Swiss Society of Rheumatology (SGT) and participating medical scientific specialist societies and other organizations]","volume":"77","author":"Buttgereit","year":"2018","journal-title":"Z Rheumatol"},{"key":"2026022606033325800_keaf646-B7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/annrheumdis-2020-217139","article-title":"EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors","volume":"80","author":"Kostine","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026022606033325800_keaf646-B8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00393-025-01667-3","article-title":"[S2e guidelines on the treatment of polymyalgia rheumatica: update 2024: evidence-based guidelines of the German Society for Rheumatology and Clinical Immunology (DGRh), the Austrian Society for Rheumatology and Rehabilitation (OGR) and the Swiss Society for Rheumatology (SGR) and the participating medical scientific specialist societies and other organizations]","volume":"84","author":"Buttgereit","year":"2025","journal-title":"Z Rheumatol"},{"key":"2026022606033325800_keaf646-B9","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1093\/rheumatology\/keaf418","article-title":"Treatment and prognostic factors in polymyalgia rheumatica: a systematic literature review informing German, Austrian and Swiss guidelines","volume":"64","author":"Boyadzhieva","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033325800_keaf646-B10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard-2024-225650","article-title":"Should all patients with polymyalgia rheumatica have a vascular ultrasound assessment?","volume":"83","author":"Cowley","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026022606033325800_keaf646-B11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard-2022-223429","article-title":"Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica","volume":"83","author":"Dejaco","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026022606033325800_keaf646-B12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/ard-2023-225134","article-title":"Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group","volume":"83","author":"Keller","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026022606033325800_keaf646-B13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/kead471","article-title":"Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review","volume":"63","author":"Hysa","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033325800_keaf646-B14","doi-asserted-by":"crossref","first-page":"152260","DOI":"10.1016\/j.semarthrit.2023.152260","article-title":"Early referral of patients with suspected polymyalgia rheumatica\u2014a systematic review","volume":"63","author":"Nielsen","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2026022606033325800_keaf646-B15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/ard.2009.113555","article-title":"Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica","volume":"69","author":"Jim\u00e9nez-Palop","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026022606033325800_keaf646-B16","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00259-024-06697-8","article-title":"The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET\/CT in polymyalgia rheumatica-a prospective study of 101 patients","volume":"51","author":"Nielsen","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026022606033325800_keaf646-B17","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1093\/rheumatology\/keaf170","article-title":"The effect of prednisolone initiation and short-term discontinuation on the clinical assessment of polymyalgia rheumatica","volume":"64","author":"V\u00e5ben","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033325800_keaf646-B18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2010.133850","article-title":"Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus","volume":"70","author":"Dejaco","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2026022606033325800_keaf646-B19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/rheumatology\/keae428","article-title":"Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review","volume":"64","author":"Bolhuis","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033325800_keaf646-B20","doi-asserted-by":"crossref","first-page":"e000426","DOI":"10.1136\/rmdopen-2016-000426","article-title":"Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study","volume":"3","author":"Cutolo","year":"2017","journal-title":"RMD Open"},{"key":"2026022606033325800_keaf646-B21","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/rheumatology\/keac713","article-title":"An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists","volume":"62","author":"Donskov","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606033325800_keaf646-B22","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/RHU.0000000000001969","article-title":"Risk factors for relapse and\/or prolonged glucocorticoid therapy in polymyalgia rheumatica: multicenter study in 185 patients","volume":"30","author":"Vinicki","year":"2024","journal-title":"J Clin Rheumatol"},{"key":"2026022606033325800_keaf646-B23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41584-020-0370-z","article-title":"Views on glucocorticoid therapy in rheumatology: the age of convergence","volume":"16","author":"Buttgereit","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026022606033325800_keaf646-B24","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/annrheumdis-2021-221126","article-title":"Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2\/3 randomised controlled trial","volume":"81","author":"Bonelli","year":"2022","journal-title":"Annals of the Rheumatic Diseases"},{"key":"2026022606033325800_keaf646-B25","first-page":"2196","article-title":"Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica on glucocorticoid therapy: a randomized clinical trial","volume":"74","author":"Devauchelle","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026022606033325800_keaf646-B26","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJMoa2303452","article-title":"Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper","volume":"389","author":"Spiera","year":"2023","journal-title":"N Engl J Med"},{"key":"2026022606033325800_keaf646-B27","doi-asserted-by":"crossref","first-page":"102995","DOI":"10.1016\/j.autrev.2021.102995","article-title":"Immune system activation in polymyalgia rheumatica: which balance between autoinflammation and autoimmunity? A systematic review","volume":"21","author":"Hysa","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2026022606033325800_keaf646-B28","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2665-9913(21)00245-9","article-title":"Efficacy of rituximab in patients with polymyalgia rheumatica: a double-blind, randomised, placebo-controlled, proof-of-concept trial","volume":"3","author":"Marsman","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2026022606033325800_keaf646-B29","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2665-9913(23)00032-2","article-title":"1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial","volume":"5","author":"Bolhuis","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026022606033325800_keaf646-B30","doi-asserted-by":"crossref","first-page":"105730","DOI":"10.1016\/j.jbspin.2024.105730","article-title":"Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica","volume":"91","author":"Wendling","year":"2024","journal-title":"Joint Bone Spine"},{"key":"2026022606033325800_keaf646-B31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s41927-024-00422-6","article-title":"Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review","volume":"8","author":"Tengesdal","year":"2024","journal-title":"BMC Rheumatol"},{"key":"2026022606033325800_keaf646-B32","doi-asserted-by":"crossref","first-page":"e1004249","DOI":"10.1371\/journal.pmed.1004249","article-title":"Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): an open-label randomized controlled trial","volume":"20","author":"Ma","year":"2023","journal-title":"PLoS Med"},{"key":"2026022606033325800_keaf646-B33","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/S2665-9913(24)00270-4","article-title":"Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"7","author":"Saraux","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"2026022606033325800_keaf646-B34","doi-asserted-by":"crossref","first-page":"rkae033","DOI":"10.1093\/rap\/rkae033","article-title":"Effectiveness of methotrexate and leflunomide as corticoid-sparing drugs in patients with polymyalgia rheumatica","volume":"8","author":"Vinicki","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"2026022606033325800_keaf646-B35","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.1016\/S2665-9913(23)00246-1","article-title":"Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial","volume":"5","author":"Saraux","year":"2023","journal-title":"Lancet Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf646\/65760946\/keaf646.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf646\/65760946\/keaf646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf646\/65760946\/keaf646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:03:43Z","timestamp":1772103823000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf646\/8369094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf646","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,12,4]]},"article-number":"keaf646"}}